What are the next steps for drone delivery of medicines?
Much has been learned in the process of developing the drone-delivery scheme. Routine deliveries of medications have been made every 90 days to project patients for 18 months… read more.
Much has been learned in the process of developing the drone-delivery scheme. Routine deliveries of medications have been made every 90 days to project patients for 18 months… read more.
Ann & Robert H. Lurie Children’s Hospital of Chicago launched a newborn screening awareness campaign, with signage on public transit and billboards across Chicago urging parents to contact… read more.
In this pilot project, deliveries of medicines were made to individuals in single-family homes; the medicines were packaged in purpose-designed boxes and the recipients had to agree to… read more.
The drone delivery service had to operate within a number of ‘guard-rails’ including restrictions on the types of medicines that could be carried and the suitability of destinations. … read more.
Background and Goal: Despite the removal of the X-waiver requirement, which once restricted clinicians from prescribing buprenorphine for opioid use disorder (OUD), only a small percentage of primary care… read more.
Cindy Williams, Vice President and Chief Pharmacy Officer at Riverside Health, Virginia, USA, is leading a multidisciplinary project to implement medication delivery by drone in order to improve… read more.
Almost 50 million Americans—disproportionately in rural areas—must drive 25 miles or more to access a gastroenterologist for diagnosis and treatment of issues involving the digestive system, according to… read more.
A clinical trial comparing a one-page medication handout proposed by the U.S. Food and Drug Administration (FDA) with an updated version developed by researchers at the University of… read more.
A meta-analysis evaluating bleeding risks among atrial fibrillation (AF) patients treated with therapeutic-dose non-vitamin K oral anticoagulants (NOACs) and single antiplatelet therapy (aspirin) indicates that rates of major… read more.
A national shortage in a common treatment for attention-deficit hyperactivity disorder was associated with changes in stimulant prescriptions filled for children over recent years, a new study suggests…. read more.
Swedish pharmacy personnel report a deteriorating climate as regards patient safety, according to a study from the University of Gothenburg. Just under four in ten have a positive… read more.
Supernus Pharmaceuticals, Inc .announced that the FDA has approved an update for the label for Qelbree (viloxazine extended-release capsules) to include new pharmacodynamic data in Section 12.2. The… read more.